Sasivimol Rattanasiri

ORCID: 0000-0001-7213-6116 · 8 papers in corpus · active 2013-2020

Study types

  • article 7
  • review 1

Condition tags

  • endometriosis 4
  • endometrioma 4
  • adenomyosis 1
review 2020
Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta‐analysis
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.16366

BACKGROUND: The efficacy of hormonal regimens for the prevention of endometrioma recurrence in women who have undergone conservative surgery is still controversial. OBJECTIVE: To compare the efficacy of different hormonal regimens in this c…

article 2020
Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta‐analysis
·doi:10.60692/jrkh9-t3221

The efficacy of hormonal regimens for the prevention of endometrioma recurrence in women who have undergone conservative surgery is still controversial.To compare the efficacy of different hormonal regimens in this context and to rank them.…

article 2020
Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta‐analysis
·doi:10.60692/jm2ya-nfm30

The efficacy of hormonal regimens for the prevention of endometrioma recurrence in women who have undergone conservative surgery is still controversial.To compare the efficacy of different hormonal regimens in this context and to rank them.…

article 2017
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial
BMC women's health ·doi:10.1186/s12905-017-0446-3

Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattract…

article 2017
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial
·doi:10.60692/012f2-g2169

Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattract…

article 2017
Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial
·doi:10.60692/nm0rb-15t96

Simvastatin is a promising new drug for the treatment of endometriosis. It is a cholesterol-lowering drug that acts by inhibiting HMG-CoA reductase, resulting in a decrease in mevalonate, a precursor of cholesterol and monocyte chemoattract…

article 2014
Comparative study of nerve fiber density between adenomyosis patients with moderate to severe pain and mild pain.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet

BACKGROUND: Since some retrospective studies have given inconsistent findings about innervation in adenomyosis, its role in the pain mechanism is still inconclusive. OBJECTIVE: Define the nerve fiber density in adenomyotic tissue as it corr…

article 2013
Effect of DMPA on IL-1 Alpha in Serum of Women with Endometrioma

Objective: To study the effect of DMPA on serum IL-1α in women with endometrioma undergoing the conservative surgery.Materials and methods:A randomized clinical trial was performed in thirty-five women with endometrioma who underwent conser…